Cash flow CRISPR Therapeutics AG

Stocks

CRSP

CH0334081137

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 21/07/2026 am IST			After hours 05:30:00 am
46.99 ^USD	-1.65%		49.78	+5.93%

30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark	CI
30/06	CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark	CI

d267466cc72a4c7f10191ca.tmcseRaIal3tFxVUoCTG-b2czk6ztU61ktEs2qmzIoM.4yN1THq7LSqLJXIZkGmovfDv-QrgwQPC6KBHncH0Y9vhAW46Rf1eNoBdJQ

Published financial data: CRISPR THERAPEUTICS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	91Cr	11.98L	37Cr	3.73Cr	35.1L
Total Revenues	91Cr	11.98L	37Cr	3.73Cr	35.1L
Cost of Goods Sold, Total	44Cr	57Cr	52Cr	43Cr	50Cr
Gross Profit	48Cr	-57Cr	-15Cr	-39Cr	-49Cr
Selling General & Admin Expenses, Total	10Cr	10Cr	7.62Cr	7.3Cr	7.35Cr
Other Operating Expenses, Total	10Cr	10Cr	7.62Cr	7.3Cr	7.35Cr
Operating Income	37Cr	-67Cr	-22Cr	-47Cr	-57Cr
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	60.03L	2.27Cr	7.18Cr	10Cr	-
Net Interest Expenses	60.03L	2.27Cr	7.18Cr	10Cr	-
Income (Loss) On Equity Invest.	-	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	-	8.66Cr
EBT, Excl. Unusual Items	38Cr	-65Cr	-15Cr	-36Cr	-48Cr
In Process R&D Expenses	-	-	-	-	-9.63Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	38Cr	-65Cr	-15Cr	-36Cr	-58Cr
Income Tax Expense	18.7L	-3L	28.88L	35.87L	36.34L
Earnings From Continuing Operations	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Net Income to Company	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Minority Interest	-	-	-	-	-
Net Income - (IS)	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Net Income to Common Incl Extra Items	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Net Income to Common Excl. Extra Items	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Per Share Items
Net EPS - Basic	4.97	-8.36	-1.94	-4.34	-6.47
Basic EPS - Continuing Operations	4.97	-8.36	-1.94	-4.34	-6.47
Basic Weighted Average Shares Outstanding	7.59Cr	7.77Cr	7.92Cr	8.44Cr	8.99Cr
Net EPS - Diluted	4.7	-8.36	-1.94	-4.34	-6.47
Diluted EPS - Continuing Operations	4.7	-8.36	-1.94	-4.34	-6.47
Diluted Weighted Average Shares Outstanding	8.04Cr	7.77Cr	7.92Cr	8.44Cr	8.99Cr
Normalized Basic EPS	3.12	-5.23	-1.19	-2.69	-3.35
Normalized Diluted EPS	2.95	-5.23	-1.19	-2.69	-3.35
Supplemental Items
EBITDA	39Cr	-65Cr	-20Cr	-45Cr	-55Cr
EBITA	37Cr	-67Cr	-22Cr	-47Cr	-57Cr
EBIT	37Cr	-67Cr	-22Cr	-47Cr	-57Cr
EBITDAR	43Cr	-60Cr	-16Cr	-41Cr	-51Cr
Total Revenues (As Reported)	91Cr	11.98L	37Cr	3.73Cr	35.1L
Effective Tax Rate - (Ratio)	0.49	0.05	-1.92	-0.99	-0.63
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	1L	7L	33.12L	40.71L	27.19L
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	17.48L	-10.1L	-4L	-5L	9L
Normalized Net Income	24Cr	-41Cr	-9.42Cr	-23Cr	-30Cr
Supplemental Operating Expense Items
General and Administrative Expenses	10Cr	10Cr	7.62Cr	7.3Cr	7.35Cr
Research And Development Expense From Footnotes	44Cr	46Cr	39Cr	32Cr	28Cr
Net Rental Expense, Total	3.68Cr	4.76Cr	4.01Cr	3.62Cr	3.65Cr
Stock-Based Comp., COGS (Total)	5.97Cr	5.4Cr	4.64Cr	4.79Cr	3.44Cr
Stock-Based Comp., G&A Exp. (Total)	4.27Cr	4.4Cr	3.47Cr	3.86Cr	3.81Cr
Total Stock-Based Compensation	10Cr	9.79Cr	8.1Cr	8.66Cr	7.25Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	92Cr	21Cr	39Cr	30Cr	35Cr
Short Term Investments	145.61Cr	160.34Cr	130.42Cr	160.56Cr	162.83Cr
Total Cash And Short Term Investments	237.91Cr	181.53Cr	169.37Cr	190.38Cr	197.58Cr
Accounts Receivable, Total	3L	-	20Cr	2.5Cr	-
Other Receivables	84L	84L	65L	21L	-
Total Receivables	87.05L	84L	21Cr	2.71Cr	-
Prepaid Expenses	2.97Cr	2.88Cr	78.86L	62.06L	59.53L
Restricted Cash	-	5L	-	-	38.9L
Total Current Assets	241.75Cr	185.3Cr	190.81Cr	193.71Cr	198.57Cr
Gross Property Plant And Equipment	35Cr	35Cr	36Cr	35Cr	34Cr
Accumulated Depreciation	-3.78Cr	-3.38Cr	-5.34Cr	-7.23Cr	-9.11Cr
Net Property Plant And Equipment	31Cr	32Cr	31Cr	28Cr	25Cr
Long-term Investments	-	5.31Cr	19.73L	-	2.26Cr
Other Intangibles, Total	1L	71T	16T	-	-
Other Long-Term Assets, Total	2.22Cr	1.63Cr	1.36Cr	2.73Cr	93.97L
Total Assets	275.19Cr	224.31Cr	222.96Cr	224.2Cr	226.52Cr
Liabilities
Accounts Payable, Total	1.48Cr	2.74Cr	3.81Cr	1.47Cr	1.11Cr
Accrued Expenses, Total	7.78Cr	7.25Cr	4.07Cr	3.94Cr	3.45Cr
Current Portion of Leases	1.22Cr	1.58Cr	1.56Cr	1.73Cr	1.86Cr
Current Income Taxes Payable	7L	1L	4L	5L	11.13L
Unearned Revenue Current, Total	10.11L	-	41.05L	38.45L	1.58Cr
Other Current Liabilities	1.34Cr	52L	98.08L	1.21Cr	6.81Cr
Total Current Liabilities	12Cr	12Cr	11Cr	8.78Cr	15Cr
Long-Term Leases	21Cr	23Cr	22Cr	21Cr	19Cr
Unearned Revenue Non Current	1.23Cr	1.23Cr	1.4Cr	1.23Cr	-
Other Non Current Liabilities	73.39L	59.69L	10L	34.44L	61.42L
Total Liabilities	35Cr	37Cr	35Cr	31Cr	34Cr
Common Stock, Total	23.91L	24.41L	24.97L	26.98L	30.87L
Additional Paid In Capital	259.81Cr	273.48Cr	287.82Cr	329.36Cr	386.15Cr
Retained Earnings	-20Cr	-85Cr	-100Cr	-136.6Cr	-194.76Cr
Treasury Stock	-63T	-63T	-62T	-62T	-60T
Comprehensive Income and Other	-50.67L	-1.56Cr	19.13L	18.4L	48.21L
Total Common Equity	239.95Cr	187.55Cr	188.28Cr	193.21Cr	192.18Cr
Total Equity	239.95Cr	187.55Cr	188.28Cr	193.21Cr	192.18Cr
Total Liabilities And Equity	275.19Cr	224.31Cr	222.96Cr	224.2Cr	226.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	7.71Cr	7.86Cr	8.03Cr	8.58Cr	9.6Cr
ECS Total Common Shares Outstanding	7.7Cr	7.85Cr	8Cr	8.57Cr	9.59Cr
Book Value / Share	31.17	23.89	23.52	22.53	20.04
Tangible Book Value	239.93Cr	187.54Cr	188.28Cr	193.21Cr	192.18Cr
Tangible Book Value Per Share	31.16	23.89	23.52	22.53	20.04
Total Debt	23Cr	24Cr	24Cr	22Cr	21Cr
Net Debt	-215.41Cr	-162.44Cr	-145.7Cr	-168.01Cr	-176.91Cr
Debt Equivalent Oper. Leases	29Cr	38Cr	32Cr	29Cr	29Cr
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	3.63Cr	4.96Cr	5.33Cr	5.44Cr	5.63Cr
Full Time Employees	473	458	407	393	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	38Cr	-65Cr	-15Cr	-37Cr	-58Cr
Depreciation & Amortization - CF	1.8Cr	2.42Cr	1.98Cr	1.93Cr	1.95Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	1.8Cr	2.42Cr	1.98Cr	1.93Cr	1.95Cr
(Gain) Loss on Sale of Investments - (CF)	1.41Cr	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	25L	-	9.63Cr
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	10Cr	9.79Cr	8.1Cr	8.66Cr	7.25Cr
Other Operating Activities, Total	-	1.25Cr	-1.65Cr	-3.86Cr	-2.35Cr
Change In Accounts Receivable	-2L	3L	-20Cr	18Cr	2.5Cr
Change In Accounts Payable	3.75Cr	51.64L	-2.02Cr	-2.73Cr	4.49Cr
Change in Unearned Revenues	-8L	-10.11L	57.94L	-19.49L	-4L
Change in Other Net Operating Assets	-97.11L	1.54Cr	2.09Cr	1.05Cr	23.85L
Cash from Operations	54Cr	-50Cr	-26Cr	-14Cr	-35Cr
Capital Expenditure	-8.17Cr	-3.72Cr	-94.7L	-19.01L	-9L
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-25L	-	-2.5Cr
Investment in Marketable and Equity Securities, Total	-95Cr	-22Cr	39Cr	-28Cr	-58.91L
Cash from Investing	-103.54Cr	-26Cr	37Cr	-28Cr	-3.18Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Issuance of Common Stock	25Cr	3.86Cr	6.27Cr	33Cr	43Cr
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	25Cr	3.86Cr	6.27Cr	33Cr	43Cr
Foreign Exchange Rate Adjustments	-11T	-80T	73T	-21T	95T
Miscellaneous Cash Flow Adjustments	-	-	-1T	-	-
Net Change in Cash	-25Cr	-72Cr	18Cr	-9.13Cr	4.93Cr
Supplemental Items
Levered Free Cash Flow	28Cr	-34Cr	-24Cr	-2.93Cr	-21Cr
Unlevered Free Cash Flow	28Cr	-34Cr	-24Cr	-2.93Cr	-21Cr
Change In Net Working Capital	-1.27Cr	17.84L	19Cr	-16Cr	-8.35Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.19	-16.85	-6.22	-13.04	-15.76
Return on Total Capital	10.73	-17.74	-6.56	-13.64	-16.58
Return On Equity %	18.59	-30.42	-8.17	-19.2	-30.18
Return on Common Equity	18.59	-30.42	-8.17	-19.2	-30.18
Margin Analysis
Gross Profit Margin %	52.06	-47.64T	-39.43	-1.05T	-14.1T
SG&A Margin	11.24	8.55T	20.52	195.58	2.1T
EBITDA Margin %	42.79	-54.17T	-54.61	-1.2T	-15.64T
EBITA Margin %	40.82	-56.19T	-59.95	-1.25T	-16.19T
EBIT Margin %	40.82	-56.19T	-59.95	-1.25T	-16.19T
Income From Continuing Operations Margin %	41.28	-54.27T	-41.38	-981.54	-16.57T
Net Income Margin %	41.28	-54.27T	-41.38	-981.54	-16.57T
Net Avail. For Common Margin %	41.28	-54.27T	-41.38	-981.54	-16.57T
Normalized Net Income Margin	25.93	-33.94T	-25.38	-607.45	-8.58T
Levered Free Cash Flow Margin	31.13	-28.18T	-64.38	-78.44	-5.86T
Unlevered Free Cash Flow Margin	31.13	-28.18T	-64.38	-78.44	-5.86T
Asset Turnover
Asset Turnover	0.4	0	0.17	0.02	0
Fixed Assets Turnover	4.52	0	1.19	0.13	0.01
Receivables Turnover (Average Receivables)	4.08T	-	-	0.33	-
Short Term Liquidity
Current Ratio	20.17	15.3	17.54	22.07	13.32
Quick Ratio	19.92	15.06	17.47	22	13.25
Operating Cash Flow to Current Liabilities	4.5	-4.09	-2.39	-1.63	-2.31
Days Sales Outstanding (Average Receivables)	0.09	-	-	1.1T	-
Average Days Payable Outstanding	9.95	13.48	23.12	22.45	9.47
Long Term Solvency
Total Debt/Equity	9.38	13.01	12.67	11.58	10.76
Total Debt / Total Capital	8.57	11.51	11.25	10.38	9.71
LT Debt/Equity	8.87	12.17	11.84	10.68	9.79
Long-Term Debt / Total Capital	8.11	10.77	10.51	9.57	8.84
Total Liabilities / Total Assets	12.81	16.39	15.55	13.82	15.16
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.53	-0.41	-1.47	-0.54	-0.4
Net Debt / EBITDA	-5.03	2.7	8.96	4.09	3.45
Total Debt / (EBITDA - Capex)	0.65	-0.38	-1.39	-0.54	-0.4
Net Debt / (EBITDA - Capex)	-6.22	2.54	8.47	4.07	3.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1L	-99.87	30.89T	-89.95	-90.59
Gross Profit, 1 Yr. Growth %	-278.92	-220.6	-74.35	168.89	25.71
EBITDA, 1 Yr. Growth %	-213.39	-265.78	-68.77	120.67	22.7
EBITA, 1 Yr. Growth %	-205.39	-280.22	-66.94	109.66	21.81
EBIT, 1 Yr. Growth %	-205.39	-280.22	-66.94	109.66	21.81
Earnings From Cont. Operations, 1 Yr. Growth %	-208.25	-272.16	-76.37	138.43	58.8
Net Income, 1 Yr. Growth %	-208.25	-272.16	-76.37	138.43	58.8
Normalized Net Income, 1 Yr. Growth %	-209.04	-271.4	-76.83	140.62	32.83
Diluted EPS Before Extra, 1 Yr. Growth %	-188.85	-277.93	-76.8	123.79	49.02
Accounts Receivable, 1 Yr. Growth %	111.81	-	-	-87.5	-
Net Property, Plant and Equip., 1 Yr. Growth %	235.43	2.73	-4.56	-9.28	-10.8
Total Assets, 1 Yr. Growth %	50.54	-18.49	-0.6	0.56	1.04
Tangible Book Value, 1 Yr. Growth %	44.19	-21.84	0.39	2.62	-0.53
Common Equity, 1 Yr. Growth %	44.18	-21.84	0.39	2.62	-0.53
Cash From Operations, 1 Yr. Growth %	-326.11	-191.98	-47.48	-45.17	141.65
Capital Expenditures, 1 Yr. Growth %	345.06	-54.49	-74.53	-79.93	-51.92
Levered Free Cash Flow, 1 Yr. Growth %	-352.26	-218.52	-29.21	-87.75	602.49
Unlevered Free Cash Flow, 1 Yr. Growth %	-352.26	-218.52	-29.21	-87.75	602.49
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	77.75	29.08	-36.3	458.09	-90.28
Gross Profit, 2 Yr. CAGR %	107.88	45.74	-44.38	-16.95	83.85
EBITDA, 2 Yr. CAGR %	175.8	37.1	-28.04	-16.98	64.55
EBITA, 2 Yr. CAGR %	182.69	37.81	-22.81	-16.75	59.81
EBIT, 2 Yr. CAGR %	182.69	37.81	-22.81	-16.75	59.81
Earnings From Cont. Operations, 2 Yr. CAGR %	137.67	36.52	-36.22	-24.95	94.58
Net Income, 2 Yr. CAGR %	137.67	36.52	-36.22	-24.95	94.58
Normalized Net Income, 2 Yr. CAGR %	171.98	36.71	-36.98	-25.33	78.77
Diluted EPS Before Extra, 2 Yr. CAGR %	100.43	25.73	-35.75	-27.95	82.62
Accounts Receivable, 2 Yr. CAGR %	-90.34	-	2.46T	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	106.99	85.63	-0.98	-6.95	-10.04
Total Assets, 2 Yr. CAGR %	60.61	10.77	-9.99	-0.02	0.8
Tangible Book Value, 2 Yr. CAGR %	59.83	6.16	-11.42	1.5	1.03
Common Equity, 2 Yr. CAGR %	59.82	6.16	-11.42	1.5	1.03
Cash From Operations, 2 Yr. CAGR %	208.38	44.21	-30.5	-46.33	15.11
Capital Expenditures, 2 Yr. CAGR %	249.63	42.33	-65.96	-77.39	-68.93
Levered Free Cash Flow, 2 Yr. CAGR %	121.31	72.91	-8.4	-70.55	-7.24
Unlevered Free Cash Flow, 2 Yr. CAGR %	121.31	72.91	-8.4	-70.55	-7.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	564.1	-83.95	702.22	-65.58	43.09
Gross Profit, 3 Yr. CAGR %	62.67	73	-18.33	-5.96	-4.65
EBITDA, 3 Yr. CAGR %	36.06	132.76	-16.27	4.54	-5.43
EBITA, 3 Yr. CAGR %	32.95	143.3	-14.37	7.7	-5.49
EBIT, 3 Yr. CAGR %	32.95	143.3	-14.37	7.7	-5.49
Earnings From Cont. Operations, 3 Yr. CAGR %	31.79	113.45	-23.92	-1.02	-3.65
Net Income, 3 Yr. CAGR %	31.79	113.45	-23.92	-1.02	-3.65
Normalized Net Income, 3 Yr. CAGR %	32.16	133.18	-24.34	-1.5	-9.53
Diluted EPS Before Extra, 3 Yr. CAGR %	10.96	92.63	-28.42	-2.61	-8.2
Accounts Receivable, 3 Yr. CAGR %	51.33	-	1.02T	334.39	-
Net Property, Plant and Equip., 3 Yr. CAGR %	156.45	63.88	48.71	-3.83	-8.25
Total Assets, 3 Yr. CAGR %	77.87	28.11	6.84	-6.6	0.33
Tangible Book Value, 3 Yr. CAGR %	82.94	25.93	4.2	-6.97	0.82
Common Equity, 3 Yr. CAGR %	82.9	25.92	4.2	-6.97	0.82
Cash From Operations, 3 Yr. CAGR %	77.58	106.04	2.99	-35.78	-11.38
Capital Expenditures, 3 Yr. CAGR %	208.86	77.2	-19.8	-71.45	-70.93
Levered Free Cash Flow, 3 Yr. CAGR %	76.85	79.72	28.39	-53.16	-15.23
Unlevered Free Cash Flow, 3 Yr. CAGR %	76.85	79.72	28.39	-53.16	-15.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	181.63	-50.67	160	-33.62	37.31
Gross Profit, 5 Yr. CAGR %	66.64	81.72	5.76	28.99	12.99
EBITDA, 5 Yr. CAGR %	42.25	60.14	5.46	54.11	9.71
EBITA, 5 Yr. CAGR %	40.58	59.78	6.96	58.43	9.9
EBIT, 5 Yr. CAGR %	40.54	59.78	6.96	58.43	9.9
Earnings From Cont. Operations, 5 Yr. CAGR %	74.71	56.91	-1.42	40.52	10.76
Net Income, 5 Yr. CAGR %	74.75	56.91	-1.42	40.52	10.76
Normalized Net Income, 5 Yr. CAGR %	27.47	57.74	-1.73	47.87	6.72
Diluted EPS Before Extra, 5 Yr. CAGR %	19.97	37.36	-10.82	29.98	4.11
Accounts Receivable, 5 Yr. CAGR %	-37.34	-	369.15	-5.23	-
Net Property, Plant and Equip., 5 Yr. CAGR %	71.51	76.23	75.26	30.68	21.62
Total Assets, 5 Yr. CAGR %	51.49	52.57	35.45	16.02	4.38
Tangible Book Value, 5 Yr. CAGR %	59.5	58.5	36.87	15.52	2.92
Common Equity, 5 Yr. CAGR %	59.44	58.44	36.86	15.51	2.92
Cash From Operations, 5 Yr. CAGR %	59.11	47.88	22.03	20.3	7.68
Capital Expenditures, 5 Yr. CAGR %	93.45	36.62	27.84	-22.23	-45.12
Levered Free Cash Flow, 5 Yr. CAGR %	134.2	54.97	35.93	-12.83	12.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	99.23	54.97	35.93	-12.83	12.74